Aaron Cowen’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
18,700
0.03% 77
2026
Q1
$1.5M Buy
18,700
+7,600
+68% +$627K 0.04% 74
2025
Q4
$946K Hold
11,100
0.02% 83
2025
Q3
$863K Hold
11,100
0.02% 85
2025
Q2
$868K Hold
11,100
0.03% 84
2025
Q1
$805K Hold
11,100
0.03% 92
2024
Q4
$822K Hold
11,100
0.03% 87
2024
Q3
$732K Hold
11,100
0.02% 90
2024
Q2
$1.03M Hold
11,100
0.04% 79
2024
Q1
$1.06M Buy
+11,100
New +$932K 0.04% 88
2023
Q3
Sell
-2,300
Closed -$217K 95
2023
Q2
$217K Buy
+2,300
New +$200K 0.01% 96

Other funds holding EW

Aaron Cowen's EW Position: Q2 2026 in Review

Aaron Cowen held its Edwards Lifesciences (EW) position steady in Q2 2026 at 18,700 shares worth $1.69M. The position accounts for 0.03% of the portfolio, ranked #77.

Aaron Cowen first reported a position in EW in Q2 2023 and has held it in 11 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Aaron Cowen held 18,700 shares of Edwards Lifesciences worth $1.69M as of Q2 2026.
  • Aaron Cowen left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.03% of Aaron Cowen's portfolio in Q2 2026, its #77 holding.
  • Aaron Cowen first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 11 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.